Ionis Pharmaceuticals IONS Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Ionis Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Ionis Pharmaceuticals’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ionis Pharmaceuticals's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ionis Pharmaceuticals's shares (basic)?
- Ionis Pharmaceuticals (IONS) reported shares (basic) of 164.9M in Q1 2026.
- How has Ionis Pharmaceuticals's shares (basic) changed year-over-year?
- Ionis Pharmaceuticals's shares (basic) increased by 3.9% year-over-year, from 158.7M to 164.9M.
- What is the long-term trend for Ionis Pharmaceuticals's shares (basic)?
- Over 4 years (2021 to 2025), Ionis Pharmaceuticals's shares (basic) has grown at a 3.1% compound annual growth rate (CAGR), from 564.1M to 637.6M.
- What does shares (basic) mean?
- The average number of shares held by investors during the period.
- How do you interpret shares (basic)?
- Changes reflect share buybacks, new equity issuances, or secondary offerings that impact ownership stakes.
- How does shares (basic) compare across companies?
- Standard metric for calculating basic EPS across all public entities.